TOP STORIES

• BUSINESS Insmed CEO Sees Japan as Cornerstone of APAC Strategy, Doubling of Staff in Next 2 Years
  September 16, 2022

• BUSINESS Moderna to Have One of Industry’s Biggest Pipelines in 5 Years, Oncology Might Make Up 30% of Sales: CEO
  September 15, 2022

• BUSINESS Alnylam Japan Paints Two-Digit Annual Growth Outlook on ATTR Meds and Pipeline Drugs
  September 14, 2022

• BUSINESS Pfizer Seeks Japan Nod for BA.4/5-Adapted COVID-19 Vaccine
  September 13, 2022

• REGULATORY Japan OKs Omicron COVID-19 Vaccines from Pfizer, Moderna
  September 13, 2022

• COMMENTARY Delving into Potential Implications of Envisaged Price Revision Overhaul
  September 12, 2022

• ORGANIZATION FPMAJ-Eyed Overhaul of Price Revision Rules Likely to Curb Price Falls, Cover JP-Listed Meds, Essential Drugs and More
  September 9, 2022

• BUSINESS Lagevrio’s Normal Distribution to Start from Sept. 16: MSD
  September 9, 2022

• ACADEMIA University of Tokyo to Open Pathogen Research Facility to Drug Makers, CROs to Accelerate Vaccine Development
  September 8, 2022

• REGULATORY Pfizer/Moderna’s Omicron Vaccines on Japan Panel Agenda on Sept. 12
  September 8, 2022

• ORGANIZATION Ex-MHLW Official Isobe, Now at Self-Medication Group, Touts OTC Use to Soften Impact of Off-Year Re-Pricing
  September 7, 2022

• BUSINESS Pfizer Japan to Stop Amoxapine Shipments, Start Recall in February after Carcinogen Detection
  September 7, 2022

• REGULATORY MHLW Study Group to Ponder Support Measures for Stable Generic Supplies
  September 6, 2022

• ORGANIZATION Chuikyo Payer Rep Eyes 5%-Plus Discrepancy Threshold or Broader Coverage: 2023 Off-Year Re-Pricing
  September 5, 2022

• ACADEMIA Academic Societies Urge Japan Govt to Approve Shionogi’s COVID-19 Pill
  September 5, 2022

• ORGANIZATION FPMAJ Chief Advocates Drug Price Revision Rule Based on Appropriate Margins for Each Player
  September 2, 2022

• REGULATORY Japan to Supply AstraZeneca’s Evusheld Only for COVID-19 Prevention
  September 2, 2022

• REGULATORY New Expert Panel on Drug Distribution and Pricing Boots Up; 2-Step Proposals Eyed for Off-Year Revision, 2024 Reform
  September 1, 2022

• ORGANIZATION JPMA Proposes New Value-Based Pricing System for Innovative Meds, No Price Cut in Patent Period
  August 31, 2022

• REGULATORY University of Tokyo Selected as Flagship R&D Site to Orchestrate Japan’s Vaccine Efforts: SCARDA Project
  August 31, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 61
• 62
• 63
• 64
• 65
• 66
• 67
• 68
• 69
• …
• Next ›
• 最終 »